An analysis of tacrolimus-related complications in the first 30 days after liver transplantation
OBJECTIVES: Orthotopic liver transplantation has improved survival in patients with end-stage liver disease; however, therapeutic strategies that achieve ideal immunosuppression and avoid early complications are lacking. To correlate the dose and level of Tacrolimus with early complications, e.g., r...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2014-11-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001100745&lng=en&tlng=en |
id |
doaj-051cb814e22047f78c3b30e73946defb |
---|---|
record_format |
Article |
spelling |
doaj-051cb814e22047f78c3b30e73946defb2020-11-25T01:58:11ZengFaculdade de Medicina / USPClinics1980-53222014-11-01691174574910.6061/clinics/2014(11)07S1807-59322014001100745An analysis of tacrolimus-related complications in the first 30 days after liver transplantationLucas Souto NacifAndré Ibrahim DavidRafael Soares PinheiroMarcio Augusto DinizWellington AndrausRuy Jorge Cruz JuniorLuiz A. Carneiro D′AlbuquerqueOBJECTIVES: Orthotopic liver transplantation has improved survival in patients with end-stage liver disease; however, therapeutic strategies that achieve ideal immunosuppression and avoid early complications are lacking. To correlate the dose and level of Tacrolimus with early complications, e.g., rejection, infection and renal impairment, after liver transplantation. From November 2011 to May 2013, 44 adult liver transplant recipients were studied in this retrospective comparative study. RESULTS: The most frequent indication for liver transplantation was hepatitis C cirrhosis (47.7%), with a higher prevalence observed in male patients (68.18%). The ages of the subjects ranged from 19-71 and the median age was 55.5 years. The mean length of the hospital stay was 16.1±9.32 days and the mean Model for End-stage Liver Disease score was 26.18±4.28. There were five cases of acute cellular rejection (11.37%) and 16 cases of infection (36.37%). The blood samples that were collected and analyzed over time showed a significant correlation between the Tacrolimus blood level and the deterioration of glomerular filtration rate and serum creatinine (p<0.05). Patients with infections had a higher serum level of Tacrolimus (p = 0.012). The dose and presence of rejection were significantly different (p = 0.048) and the mean glomerular filtration rate was impaired in patients who underwent rejection compared with patients who did not undergo rejection (p = 0.0084). CONCLUSION: Blood Tacrolimus levels greater than 10 ng/ml were correlated with impaired renal function. Doses greater than 0.15 mg/kg/day were associated with the prevention of acute cellular rejection but predisposed patients to infectious disease.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001100745&lng=en&tlng=enLiver TransplantationRenal FailureEnd-Stage Liver DiseaseTacrolimusRejection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lucas Souto Nacif André Ibrahim David Rafael Soares Pinheiro Marcio Augusto Diniz Wellington Andraus Ruy Jorge Cruz Junior Luiz A. Carneiro D′Albuquerque |
spellingShingle |
Lucas Souto Nacif André Ibrahim David Rafael Soares Pinheiro Marcio Augusto Diniz Wellington Andraus Ruy Jorge Cruz Junior Luiz A. Carneiro D′Albuquerque An analysis of tacrolimus-related complications in the first 30 days after liver transplantation Clinics Liver Transplantation Renal Failure End-Stage Liver Disease Tacrolimus Rejection |
author_facet |
Lucas Souto Nacif André Ibrahim David Rafael Soares Pinheiro Marcio Augusto Diniz Wellington Andraus Ruy Jorge Cruz Junior Luiz A. Carneiro D′Albuquerque |
author_sort |
Lucas Souto Nacif |
title |
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation |
title_short |
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation |
title_full |
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation |
title_fullStr |
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation |
title_full_unstemmed |
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation |
title_sort |
analysis of tacrolimus-related complications in the first 30 days after liver transplantation |
publisher |
Faculdade de Medicina / USP |
series |
Clinics |
issn |
1980-5322 |
publishDate |
2014-11-01 |
description |
OBJECTIVES: Orthotopic liver transplantation has improved survival in patients with end-stage liver disease; however, therapeutic strategies that achieve ideal immunosuppression and avoid early complications are lacking. To correlate the dose and level of Tacrolimus with early complications, e.g., rejection, infection and renal impairment, after liver transplantation. From November 2011 to May 2013, 44 adult liver transplant recipients were studied in this retrospective comparative study. RESULTS: The most frequent indication for liver transplantation was hepatitis C cirrhosis (47.7%), with a higher prevalence observed in male patients (68.18%). The ages of the subjects ranged from 19-71 and the median age was 55.5 years. The mean length of the hospital stay was 16.1±9.32 days and the mean Model for End-stage Liver Disease score was 26.18±4.28. There were five cases of acute cellular rejection (11.37%) and 16 cases of infection (36.37%). The blood samples that were collected and analyzed over time showed a significant correlation between the Tacrolimus blood level and the deterioration of glomerular filtration rate and serum creatinine (p<0.05). Patients with infections had a higher serum level of Tacrolimus (p = 0.012). The dose and presence of rejection were significantly different (p = 0.048) and the mean glomerular filtration rate was impaired in patients who underwent rejection compared with patients who did not undergo rejection (p = 0.0084). CONCLUSION: Blood Tacrolimus levels greater than 10 ng/ml were correlated with impaired renal function. Doses greater than 0.15 mg/kg/day were associated with the prevention of acute cellular rejection but predisposed patients to infectious disease. |
topic |
Liver Transplantation Renal Failure End-Stage Liver Disease Tacrolimus Rejection |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001100745&lng=en&tlng=en |
work_keys_str_mv |
AT lucassoutonacif ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT andreibrahimdavid ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT rafaelsoarespinheiro ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT marcioaugustodiniz ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT wellingtonandraus ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT ruyjorgecruzjunior ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT luizacarneirodalbuquerque ananalysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT lucassoutonacif analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT andreibrahimdavid analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT rafaelsoarespinheiro analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT marcioaugustodiniz analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT wellingtonandraus analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT ruyjorgecruzjunior analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation AT luizacarneirodalbuquerque analysisoftacrolimusrelatedcomplicationsinthefirst30daysafterlivertransplantation |
_version_ |
1724971001851150336 |